To hear about similar clinical trials, please enter your email below

Trial Title: Portal Hypertension and Liver Resection in Patients With Hepatocellular Carcinoma

NCT ID: NCT02145013

Condition: Primary Liver Cancers

Conditions: Official terms:
Carcinoma
Carcinoma, Hepatocellular
Hypertension, Portal
Hypertension

Conditions: Keywords:
portal hypertension, hepatocellular carcinoma, resection

Study type: Observational

Overall status: Unknown status

Study design:

Time perspective: Prospective

Intervention:

Intervention type: Procedure
Intervention name: Liver resection
Description: Hepatectomy by either open, laparoscopic or robotic procedures
Arm group label: No portal hypertension
Arm group label: Portal hypertension

Summary: According to the BCLC guidelines, surgical resection of hepatocellular carcinoma complicating cirrhosis is restricted to patients with preserved liver function, single nodule without vascular invasion and with hepatic venous gradient below 10 mmHg. However, other guideline treatment, especially from eastern countries demonstrated that surgical resection is safe and feasible and provides better survival than the treatment recommended by the BCLC system for patients with similar stage. The primary goal of this study is to assess the impact of HVPG on short and long-term outcomes in HCC patients who undergo liver resection.

Detailed description: Patients with HCC and candidates for hepatectomy are classified into two groups according to the presence of portal hypertension. Short- and long-term outcomes will be compared.

Criteria for eligibility:

Study pop:
All patients with hepatocellular carcinoma

Sampling method: Probability Sample
Criteria:
Patients with hepatocellular carcinoma who undergo surgical resection (intention to treat analysis)

Gender: All

Minimum age: N/A

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Henri Mondor University Hospital

Address:
City: Creteil
Zip: 94000
Country: France

Start date: November 2013

Completion date: May 30, 2018

Lead sponsor:
Agency: Henri Mondor University Hospital
Agency class: Other

Source: Henri Mondor University Hospital

Record processing date: ClinicalTrials.gov processed this data on April 10, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT02145013

Login to your account

Did you forget your password?